Oxyview offers cost savings for the entire global oxygen industry. "It has been 90 days since the 36-month cap on oxygen equipment rental went into effect in the USA. Most providers have found a way to stay in business; although the industry is only faced with the initial challenge associated with revenue reduction and lower reimbursement. Oxyview will play a small role in a huge and growing industry by eliminating unnecessary service calls to the home oxygen patient, and easily diagnosing equipment malfunction that could lead to malpractice suits. Oxyview stands alone in the in-line gravity independent flow-meter market, with potential sales of $30M annually, and savings in the industry of 10 times that amount. One Oxyview costs less than a single service call," Stated Scott Sand, CEO and Chairman of Ingen Technologies.